ArticleCancer medicine2025
Explainable Machine Learning Model for Predicting Postoperative Survival in Patients With Locally Advanced Gastric Cancer.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeThis study aims to develop and validate an explainable machine learning model for predicting postoperative survival in patients with locally advanced gastric cancer (LAGC), optimizing predictive accuracy while ensuring clinical applicability to facilitate personalized prognostication for patients.
methodsThe study utilized data from 8616 LAGC patients who underwent gastrectomy (2004-2015) in the Surveillance, Epidemiology, and End Results (SEER) database for model development and validation, with external validation performed using 235 postoperative LAGC cases (2016-2022) from Maoming People's Hospital (Maoming, China). Five predictive models-Cox proportional hazards model (CoxPH), random survival forest (RSF), extreme gradient boosting (XGBoost), gradient boosting machine (GBM), and DeepSurv-were developed using the training set. Model performance was evaluated using the concordance index (C-index), area under the receiver operating characteristic curve (AUROC), and Brier score. Additionally, 1-, 3-, and 5-year receiver operating characteristic curves (ROC), calibration curves, and decision curve analysis (DCA) were employed for further assessment. The optimal model was interpreted using explainability tools such as SurvSHAP and SurvLIME. Finally, an interactive prediction tool was created to provide personalized survival evaluation for LAGC patients.
resultsRSF exhibited the highest predictive performance, with a C-index of 0.732 (95% CI: 0.720-0.745) in the validation set and 0.723 (95% CI: 0.696-0.755) in the external validation set. The 1-, 3-, and 5-year AUROCs were 0.771, 0.803, and 0.809 in the validation set, and 0.802, 0.711, and 0.721 in the external validation set. Explainability analysis identified lymph node ratio (LNR), AJCC stage, and age as the most influential prognostic factors. An interactive prediction tool was developed to provide individualized prognosis visualization.
conclusionThis study developed an RSF-based model to predict postoperative survival in LAGC patients, emphasizing the prognostic significance of LNR, AJCC stage, and age. The interactive prediction tool enhances clinical utility, facilitating personalized treatment decision-making for physicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.